Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Barnes, D.R.; Rookus, M.A.; McGuffog, L.; Leslie, G.; Mooij, T.M.; Dennis, J.; Mavaddat, N.; Adlard, J.; Ahmed, M.; Aittomaki, K.; Andrieu, N.; Andrulis, I.L.; Arnold, N.; Arun, B.K.; Azzollini, J.; Balmana, J.; Barkardottir, R.B.; Barrowdale, D.; Benitez, J.; Berthet, P.; Bialkowska, K.; Blanco, A.M.; Blok, M.J.; Bonanni, B.; Boonen, S.E.; Borg, A.; Bozsik, A.; Bradbury, A.R.; Brennan, P.; Brewer, C.; Brunet, J.; Buys, S.S.; Caldes, T.; Caligo, M.A.; Campbell, I.; Christensen, L.L.; Chung, W.K.; Claes, K.B.M.; Colas, C.; Collonge-Rame, M.A.; Cook, J.; Daly, M.B.; Davidson, R.; Hoya, M. de la; Putter, R. de; Delnatte, C.; Devilee, P.; Diez, O.; Ding, Y.C.; Domchek, S.M.; Dorfling, C.M.; Dumont, M.; Eeles, R.; Ejlertsen, B.; Engel, C.; Evans, D.G.; Faivre, L.; Foretova, L.; Fostira, F.; Friedlander, M.; Friedman, E.; Frost, D.; Ganz, P.A.; Garber, J.; Gehrig, A.; Gerdes, A.M.; Gesta, P.; Giraud, S.; Glendon, G.; Godwin, A.K.; Goldgar, D.E.; Gonzalez-Neira, A.; Greene, M.H.; Gschwantler-Kaulich, D.; Hahnen, E.; Hamann, U.; Hanson, H.; Hentschel, J.; Hogervorst, F.B.L.; Hooning, M.J.; Horvath, J.; Hu, C.L.; Hulick, P.J.; Imyanitov, E.N.; Isaacs, C.; Izatt, L.; Izquierdo, A.; Jakubowska, A.; James, P.A.; Janavicius, R.; John, E.M.; Joseph, V.; Karlan, B.Y.; Kast, K.; Koudijs, M.; Kruse, T.A.; Kwong, A.; Laitman, Y.; Lasset, C.; Lazaro, C.; Lester, J.; Lesueur, F.; Liljegren, A.; Loud, J.T.; Lubinski, J.; Mai, P.L.; Manoukian, S.; Mari, V.; Mebirouk, N.; Meijers-Heijboer, H.E.J.; Meindl, A.; Mensenkamp, A.R.; Miller, A.; Montagna, M.; Mouret-Fourme, E.; Mukherjee, S.; Mulligan, A.M.; Nathanson, K.L.; Neuhausen, S.L.; Nevanlinna, H.; Niederacher, D.; Nielsen, F.C.; Nikitina-Zake, L.; Nogues, C.; Olah, E.; Olopade, O.I.; Ong, K.R.; O'Shaughnessy-Kirwan, A.; Osorio, A.; Ott, C.E.; Papi, L.; Park, S.K.; Parsons, M.T.; Pedersen, I.S.; Peissel, B.; Peixoto, A.; Peterlongo, P.; Pfeiler, G.; Phillips, K.A.; Prajzendanc, K.; Pujana, M.A.; Radice, P.; Ramser, J.; Ramus, S.J.; Rantala, J.; Rennert, G.; Risch, H.A.; Robson, M.; Ronlund, K.; Salani, R.; Schuster, H.; Senter, L.; Shah, P.D.; Sharma, P.; Side, L.E.; Singer, C.F.; Slavin, T.P.; Soucy, P.; Southey, M.C.; Spurdle, A.B.; Steinemann, D.; Steinsnyder, Z.; Stoppa-Lyonnet, D.; Sutter, C.; Tan, Y.Y.; Teixeira, M.R.; Teo, S.H.; Thull, D.L.; Tischkowitz, M.; Tognazzo, S.; Toland, A.E.; Trainer, A.H.; Tung, N.; Engelen, K. van; Rensburg, E.J. van; Vega, A.; Vierstraete, J.; Wagner, G.; Walker, L.; Wang-Gohrke, S.; Wappenschmidt, B.; Weitzel, J.N.; Yadav, S.; Yang, X.; Yannoukakos, D.; Zimbalatti, D.; Offit, K.; Thomassen, M.; Couch, F.J.; Schmutzler, R.K.; Simard, J.; Easton, D.F.; Chenevix-Trench, G.; Antoniou, A.C.; GEMO Study Collaborators; EMBRACE Collaborators; KConFab Investigators; HEBON Investigators; GENEPSO Investigators; Consortium Investigators Modifiers

doi:doi:10.1038/s41436-020-0862-x

Persistent URL of this record https://hdl.handle.net/1887/3184439

View statistics

In Collections

This item can be found in the following collections:

Medicine / Leiden University Medical Centre (LUMC)

Barnes, D.R.; Rookus, M.A.; McGuffog, L.; Leslie, G.; Mooij, T.M.; Dennis, J.; ... ; Consortium Investigators Modifiers (2020)

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Article / Letter to editor

Purpose We assessed the associations between population-based polygenic risk scores (PRS) for breast (BC) or epithelial ovarian cancer (EOC) with cancer risks forBRCA1andBRCA2pathogenic variant carriers. Methods Retrospective cohort data on 18,935BRCA1and 12,339BRCA2female pathogenic variant carriers of European ancestry were available. Three versions of a 313 single-nucleotide polymorphism (SNP) BC PRS were evaluated based on whether they predict overall, estrogen receptor (ER)-negative, or ER-positive BC, and two PRS for overall or high-grade serous EOC. Associations were validated in a prospective cohort. Results The ER-negative PRS showed the strongest association with BC risk forBRCA1carriers (hazard ratio [HR] per standard deviation = 1.29 [95% CI 1.25-1.33],P = 3x10(-72)). ForBRCA2, the strongest association was with overall BC PRS (HR = 1.31 [95% CI 1.27-1.36],P = 7x10(-50)). HR estimates decreased significantly with age and there was evidence for differences in associations...Show morePurpose We assessed the associations between population-based polygenic risk scores (PRS) for breast (BC) or epithelial ovarian cancer (EOC) with cancer risks forBRCA1andBRCA2pathogenic variant carriers. Methods Retrospective cohort data on 18,935BRCA1and 12,339BRCA2female pathogenic variant carriers of European ancestry were available. Three versions of a 313 single-nucleotide polymorphism (SNP) BC PRS were evaluated based on whether they predict overall, estrogen receptor (ER)-negative, or ER-positive BC, and two PRS for overall or high-grade serous EOC. Associations were validated in a prospective cohort. Results The ER-negative PRS showed the strongest association with BC risk forBRCA1carriers (hazard ratio [HR] per standard deviation = 1.29 [95% CI 1.25-1.33],P = 3x10(-72)). ForBRCA2, the strongest association was with overall BC PRS (HR = 1.31 [95% CI 1.27-1.36],P = 7x10(-50)). HR estimates decreased significantly with age and there was evidence for differences in associations by predicted variant effects on protein expression. The HR estimates were smaller than general population estimates. The high-grade serous PRS yielded the strongest associations with EOC risk forBRCA1(HR = 1.32 [95% CI 1.25-1.40],P = 3x10(-22)) andBRCA2(HR = 1.44 [95% CI 1.30-1.60],P = 4x10(-12)) carriers. The associations in the prospective cohort were similar. Conclusion Population-based PRS are strongly associated with BC and EOC risks forBRCA1/2carriers and predict substantial absolute risk differences for women at PRS distribution extremes.Show less